Format

Send to

Choose Destination
Pediatr Blood Cancer. 2008 Apr;50(4):896-8.

Pneumocystis pneumonia in children receiving chemotherapy.

Author information

1
Divisions of Pediatric Hematology/Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.

Abstract

Pneumocystis pneumonia (PCP) is a serious complication of chemotherapy-induced immunosuppression. Trimethoprim-sulfamethoxazole (TMP-SMZ) given twice daily, 3 days every week is considered the best form of prophylaxis for PCP. We evaluated PCP prophylaxis in all children up to 18 years of age undergoing cancer chemotherapy over a 2-year period. Four children were diagnosed with PCP over 24 months. Two of 12 children on intravenous pentamidine, 1 of 143 on TMP-SMZ and 1 of 36 on dapsone for PCP prophylaxis developed PCP. Intravenous pentamidine may not be as effective as previously considered and should be used with caution.

PMID:
17458875
DOI:
10.1002/pbc.21202
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center